Overview
Giuseppe Liberatore practices in Milan, Italy. Mr. Liberatore is rated as a Distinguished expert by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. His top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Polyradiculoneuritis, Multiple Sclerosis (MS), and Chronic Demyelinizing Neuropathy with IgM Monoclonal.
His clinical research consists of co-authoring 35 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles in the study of Chronic Inflammatory Demyelinating Polyneuropathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Inflammatory Demyelinating PolyneuropathyMr. Liberatore isDistinguished. Learn about Chronic Inflammatory Demyelinating Polyneuropathy.
- Chronic PolyradiculoneuritisMr. Liberatore isDistinguished. Learn about Chronic Polyradiculoneuritis.
- Experienced
- Accessory Deep Peroneal NerveMr. Liberatore isExperienced. Learn about Accessory Deep Peroneal Nerve.
- Carpal Tunnel SyndromeMr. Liberatore isExperienced. Learn about Carpal Tunnel Syndrome.
- Chronic Demyelinizing Neuropathy with IgM Monoclonal
- GastroparesisMr. Liberatore isExperienced. Learn about Gastroparesis.
- Guillain-Barre SyndromeMr. Liberatore isExperienced. Learn about Guillain-Barre Syndrome.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)